dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse

This website has run out of funding so feel free to contribute if you can afford it (see footer)

Author Topic: Aniracetam  (Read 2122 times)

Offline sk8phaze (OP)

  • Junky Deluxe
  • Full Member
  • ***
  • SA_Chat+
  • **
  • Join Date: Jul 2015
  • Location: So Cal
  • Posts: 295
  • Reputation Power: 0
  • sk8phaze has hidden their reputation power
  • Gender: Male
  • Last Login:April 26, 2021, 09:11:55 AM
  • Sk8phaze
Aniracetam
« on: December 24, 2015, 10:17:02 PM »
Aniracetam (Draganon, Sarpul, Ampamet, Memodrin, Referan), also known as N-anisoyl-2-pyrrolidinone, is an ampakine nootropic of the racetam chemical class purported to be considerably more potent than piracetam. It is lipid-soluble and has possible cognition-enhancing effects. It has been tested in animals extensively, Alzheimer's patients, and temporarily impaired healthy subjects. It has shown potential as an anxiolytic in three clinical animal models. It is sold in Europe as a prescription drug,[1] but it is not approved by the Food and Drug Administration for use in the United States.


Pharmacology
Aniracetam has also been shown to positively modulate the AMPA receptor[2] and was used as the parent compound to derive a class of drugs known as the ampakines that are being investigated as nootropics and neuroprotective drugs for the treatment of Alzheimer's disease and other neurodegenerative conditions.[3]

After a confirmed test of the anxiolytic efficacy in a mouse model, haloperidol, mecamylamine, and ketanserin were applied to determine the pathways aniracetam depends on to exert its anti-anxiety effects. Haloperidol completely reversed the anxiolytic effects, and mecamylamine and ketanserin nearly completely reversed the effects. This shows that aniracetam's anxiolytic mechanism is possibly mediated through D2, nACh, or 5-HT2A receptor activity.[4]

The main metabolite of aniracetam (70-80%), N-anisoyl-GABA, reproduces many of the effects of aniracetam.[5][6] 2-Pyrrolidinone and p-anisilic acid are additional metabolites of the drug (20-30%), both of which are also active.[6]


Pharmacokinetics
When ingested orally aniracetam is quickly broken down via first pass hepatic metabolism. The primary metabolites of aniracetam are N-anisoyl-GABA, 2-pyrrolidone, and anisic acid.[10] Plasma concentrations are generally in the 5–15 μg/L range for aniracetam and 5-15 mg/L range for N-anisoyl-GABA, a pharmacologically-active metabolite, during the first few hours after recreational usage of the drug. These two plasma species may be measured by liquid chromatography-mass spectrometry.[11][12][13]

friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
You cant rip out a single  page of your life but you can throw the whole book in the fire. -george sand

We die only once, but for such a long time.
                                 (Unknown)

Tags:
 


dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE


Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal